Clinical Trials Browser

Phase 3 × Unknown × Shock, Septic × Clear all

NCT05443854 2022-07-05

Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)

Phase 3 Unknown

Other hematologic neoplasm

Neoplasms, Shock, Septic, Sepsis, Hematologic Neoplasms